Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Impact of ABCC2, ABCG2 and SLCO1B1 polymorphisms on the pharmacokinetics of pitavastatin in humans.

Oh ES, Kim CO, Cho SK, Park MS, Chung JY.

Drug Metab Pharmacokinet. 2013;28(3):196-202. Epub 2012 Sep 25.

PMID:
23007012
[PubMed - indexed for MEDLINE]
Free Article
2.

SLCO1B1 (OATP1B1, an uptake transporter) and ABCG2 (BCRP, an efflux transporter) variant alleles and pharmacokinetics of pitavastatin in healthy volunteers.

Ieiri I, Suwannakul S, Maeda K, Uchimaru H, Hashimoto K, Kimura M, Fujino H, Hirano M, Kusuhara H, Irie S, Higuchi S, Sugiyama Y.

Clin Pharmacol Ther. 2007 Nov;82(5):541-7. Epub 2007 Apr 25.

PMID:
17460607
[PubMed - indexed for MEDLINE]
3.

Influence of ABCC2, SLCO1B1, and ABCG2 polymorphisms on the pharmacokinetics of olmesartan.

Kim CO, Cho SK, Oh ES, Park MS, Chung JY.

J Cardiovasc Pharmacol. 2012 Jul;60(1):49-54. doi: 10.1097/FJC.0b013e3182576098.

PMID:
22494992
[PubMed - indexed for MEDLINE]
4.

Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers.

Chung JY, Cho JY, Yu KS, Kim JR, Oh DS, Jung HR, Lim KS, Moon KH, Shin SG, Jang IJ.

Clin Pharmacol Ther. 2005 Oct;78(4):342-50.

PMID:
16198653
[PubMed - indexed for MEDLINE]
5.

CYP2C9*3(1075A > C), ABCB1 and SLCO1B1 genetic polymorphisms and gender are determinants of inter-subject variability in pitavastatin pharmacokinetics.

Zhou Q, Chen QX, Ruan ZR, Yuan H, Xu HM, Zeng S.

Pharmazie. 2013 Mar;68(3):187-94.

PMID:
23556337
[PubMed - indexed for MEDLINE]
6.

Simvastatin pharmacokinetics in healthy Chinese subjects and its relations with CYP2C9, CYP3A5, ABCB1, ABCG2 and SLCO1B1 polymorphisms.

Zhou Q, Ruan ZR, Jiang B, Yuan H, Zeng S.

Pharmazie. 2013 Feb;68(2):124-8.

PMID:
23469684
[PubMed - indexed for MEDLINE]
7.

The association of the UGT1A8, SLCO1B3 and ABCC2/ABCG2 genetic polymorphisms with the pharmacokinetics of mycophenolic acid and its phenolic glucuronide metabolite in Chinese individuals.

Geng F, Jiao Z, Dao YJ, Qiu XY, Ding JJ, Shi XJ, Li ZD, Zhong MK.

Clin Chim Acta. 2012 Apr 11;413(7-8):683-90. doi: 10.1016/j.cca.2011.12.003. Epub 2011 Dec 22.

PMID:
22227166
[PubMed - indexed for MEDLINE]
8.

Effects of the SLCO1B1*15 allele on the pharmacokinetics of pitavastatin.

Choi CI, Lee YJ, Lee HI, Kim BH, Kim MJ, Jang CG, Bae JW, Lee SY.

Xenobiotica. 2012 May;42(5):496-501. doi: 10.3109/00498254.2011.632030. Epub 2011 Nov 11.

PMID:
22077103
[PubMed - indexed for MEDLINE]
9.

ABCB1 gene polymorphisms, ABCB1 haplotypes and ABCG2 c.421c > A are determinants of inter-subject variability in rosuvastatin pharmacokinetics.

Zhou Q, Ruan ZR, Yuan H, Xu DH, Zeng S.

Pharmazie. 2013 Feb;68(2):129-34.

PMID:
23469685
[PubMed - indexed for MEDLINE]
10.

Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans.

Kivistö KT, Niemi M.

Pharm Res. 2007 Feb;24(2):239-47. Epub 2006 Dec 20. Review.

PMID:
17177112
[PubMed - indexed for MEDLINE]
11.

Effects of grapefruit juice and SLCO1B1 388A>G polymorphism on the pharmacokinetics of pitavastatin.

Hu M, Mak VW, Yin OQ, Chu TT, Tomlinson B.

Drug Metab Pharmacokinet. 2013;28(2):104-8. Epub 2012 Jul 31.

PMID:
22850760
[PubMed - indexed for MEDLINE]
Free Article
12.

Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.

Miura M, Satoh S, Inoue K, Kagaya H, Saito M, Inoue T, Suzuki T, Habuchi T.

Eur J Clin Pharmacol. 2007 Dec;63(12):1161-9. Epub 2007 Sep 29.

PMID:
17906856
[PubMed - indexed for MEDLINE]
13.

Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers.

Akamine Y, Miura M, Sunagawa S, Kagaya H, Yasui-Furukori N, Uno T.

Xenobiotica. 2010 Nov;40(11):782-9. doi: 10.3109/00498254.2010.515318.

PMID:
20839930
[PubMed - indexed for MEDLINE]
14.

Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs.

Ieiri I, Higuchi S, Sugiyama Y.

Expert Opin Drug Metab Toxicol. 2009 Jul;5(7):703-29. doi: 10.1517/17425250902976854. Review.

PMID:
19442037
[PubMed - indexed for MEDLINE]
15.

Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition.

Ni W, Ji J, Dai Z, Papp A, Johnson AJ, Ahn S, Farley KL, Lin TS, Dalton JT, Li X, Jarjoura D, Byrd JC, Sadee W, Grever MR, Phelps MA.

PLoS One. 2010 Nov 1;5(11):e13792. doi: 10.1371/journal.pone.0013792.

PMID:
21072184
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics.

Niemi M, Arnold KA, Backman JT, Pasanen MK, Gödtel-Armbrust U, Wojnowski L, Zanger UM, Neuvonen PJ, Eichelbaum M, Kivistö KT, Lang T.

Pharmacogenet Genomics. 2006 Nov;16(11):801-8.

PMID:
17047488
[PubMed - indexed for MEDLINE]
17.

Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients.

Miura M, Kagaya H, Satoh S, Inoue K, Saito M, Habuchi T, Suzuki T.

Ther Drug Monit. 2008 Oct;30(5):559-64. doi: 10.1097/FTD.0b013e3181838063.

PMID:
18695635
[PubMed - indexed for MEDLINE]
18.

OATP1B1 388A>G polymorphism and pharmacokinetics of pitavastatin in Chinese healthy volunteers.

Wen J, Xiong Y.

J Clin Pharm Ther. 2010 Feb;35(1):99-104. doi: 10.1111/j.1365-2710.2009.01071.x.

PMID:
20175818
[PubMed - indexed for MEDLINE]
19.

Quantitative population pharmacokinetic analysis of pravastatin using an enterohepatic circulation model combined with pharmacogenomic Information on SLCO1B1 and ABCC2 polymorphisms.

Ide T, Sasaki T, Maeda K, Higuchi S, Sugiyama Y, Ieiri I.

J Clin Pharmacol. 2009 Nov;49(11):1309-17. doi: 10.1177/0091270009341960. Epub 2009 Sep 23.

PMID:
19776292
[PubMed - indexed for MEDLINE]
20.

Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males.

Zhang W, Yu BN, He YJ, Fan L, Li Q, Liu ZQ, Wang A, Liu YL, Tan ZR, Fen-Jiang, Huang YF, Zhou HH.

Clin Chim Acta. 2006 Nov;373(1-2):99-103. Epub 2006 May 13.

PMID:
16784736
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk